We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $786B
1-Year Est. Return 40.34%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+14.65%
1 Year Est. Return
+40.34%
3 Year Est. Return
+112.81%
5 Year Est. Return
+128.34%
10 Year Est. Return
+452.52%
AUM
$296B
AUM Growth
+$30.5B
Cap. Flow
-$5.03B
Cap. Flow %
-1.7%
Top 10 Hldgs %
14.21%
Holding
9,236
New
1,125
Increased
3,976
Reduced
2,989
Closed
738

Sector Composition

Rank Sector Weight
1 Technology 10.93%
2 Financials 6.61%
3 Consumer Discretionary 6.23%
4 Healthcare 5.77%
5 Communication Services 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KPTI icon
4726
CALL
Karyopharm Therapeutics
KPTI
$45.1M
$423K ﹤0.01%
+1,820
New +$422K
WRLD icon
4727
World Acceptance Corp
WRLD
$884M
$423K ﹤0.01%
4,146
-334
-7% -$35.3K
ATOM icon
4728
Atomera
ATOM
$216M
$422K ﹤0.01%
26,180
+23,803
+1,001% +$249K
JLS icon
4729
Nuveen Mortgage and Income Fund
JLS
$95M
$421K ﹤0.01%
21,313
+2,863
+16% +$54.7K
PPH icon
4730
VanEck Pharmaceutical ETF
PPH
$991M
$421K ﹤0.01%
6,332
-595
-9% -$38.1K
ARAV
4731
DELISTED
Aravive, Inc. Common Stock
ARAV
$421K ﹤0.01%
74,691
+1,606
+2% +$8.81K
ICPT
4732
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$421K ﹤0.01%
17,039
-1,641
-9% -$54.4K
GBT
4733
DELISTED
Global Blood Therapeutics, Inc.
GBT
$421K ﹤0.01%
9,721
+7,256
+294% +$358K
MDY icon
4734
CALL
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
$420K ﹤0.01%
1,000
-14,000
-93% -$5.39M
NZAC icon
4735
State Street SPDR MSCI ACWI Climate Paris Aligned ETF
NZAC
$200M
$420K ﹤0.01%
14,732
-76
-0.5% -$2.04K
AIF
4736
DELISTED
Apollo Tactical Income Fund Inc.
AIF
$420K ﹤0.01%
29,009
-4,220
-13% -$56.6K
HCI icon
4737
HCI Group
HCI
$2.28B
$419K ﹤0.01%
8,015
+5,059
+171% +$256K
PSCC icon
4738
Invesco S&P SmallCap Consumer Staples ETF
PSCC
$42.1M
$419K ﹤0.01%
14,454
-2,757
-16% -$75.9K
TVRD
4739
Tvardi Therapeutics
TVRD
$22.1M
$419K ﹤0.01%
770
+196
+34% +$103K
ME
4740
DELISTED
23andMe Holding Co
ME
$419K ﹤0.01%
+1,832
New +$410K
DBI icon
4741
Designer Brands
DBI
$311M
$418K ﹤0.01%
54,635
-17,297
-24% -$115K
CCO icon
4742
Clear Channel Outdoor Holdings
CCO
$1.23B
$417K ﹤0.01%
252,659
-222,919
-47% -$280K
KRG icon
4743
Kite Realty
KRG
$5.27B
$417K ﹤0.01%
27,837
+27,001
+3,230% +$359K
MPA icon
4744
BlackRock MuniYield Pennsylvania Quality Fund
MPA
$144M
$417K ﹤0.01%
27,942
-7,222
-21% -$103K
DUC
4745
DELISTED
Duff & Phelps Utility & Corporate Bond Trust
DUC
$417K ﹤0.01%
41,570
-4,101
-9% -$38.8K
AXGN icon
4746
Axogen
AXGN
$2.67B
$416K ﹤0.01%
23,233
+7,804
+51% +$115K
CAE icon
4747
CAE Inc. Common Shares
CAE
$8.9B
$415K ﹤0.01%
14,973
-2,413
-14% -$51.8K
DX
4748
Dynex Capital
DX
$3.23B
$415K ﹤0.01%
23,307
+7,505
+47% +$128K
FEUZ icon
4749
First Trust Eurozone AlphaDEX
FEUZ
$134M
$415K ﹤0.01%
10,056
-174
-2% -$6.77K
RSPM icon
4750
Invesco S&P 500 Equal Weight Materials ETF
RSPM
$183M
$415K ﹤0.01%
14,895
-20
-0.1% -$520

Similar funds

UBS Group's Q4 2020 Portfolio in Review

As of Q4 2020, UBS Group held 9,236 positions worth $296B, up 11% from $265B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group's Q4 2020 filing shows 1,125 new, 3,976 increased, 2,989 reduced and 738 closed positions. Its largest new stake was Vontier: 502,899 shares worth $16.8M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.91B.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.

  • UBS Group's largest Q4 2020 buy was Vontier: 502,899 shares worth $16.8M.
  • UBS Group added most to UBS Group in Q4 2020, an estimated $475M increase.
  • UBS Group's biggest Q4 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.91B.
  • UBS Group fully exited Delphi Technologies PLC Ordinary Shares in Q4 2020, selling an estimated $96.7M.
  • UBS Group's ten largest holdings make up 14% of its $296B portfolio in Q4 2020.
  • UBS Group opened 1,125 new positions and closed 738 in Q4 2020.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $296B.

Based on UBS Group's 13F filing for Q4 2020, filed 11 Feb 2021.